Technical Updates, Financial Results, Senior Level Appointment, and Product Debut - Research Reports on PMI, Harman, Mondelez, Nike and WhiteWave

NEW YORK, August 12, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Philip Morris International Inc. (NYSE: PM), Harman International Industries Inc. (NYSE: HM), Mondelez International Inc. (NASDAQ: MDLZ), Nike Inc. (NYSE: NKE) and WhiteWave Foods Co. (NYSE: WWAV). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5662-100free.

Philip Morris International Inc. Research Reports 

On August 7, 2014, Philip Morris International Inc.'s (PMI) stock declined 0.92% to end the trading session at $82.71, following the S&P 500 that declined 0.56% over the same trading session. PMI's stock opened the session at $83.55 and oscillated in the range of $82.38 - $83.90. The stock has a 52-week high of $91.81 and a 52-week low of $75.28. Over the past six months, the stock has returned 5.89%. The full research reports on PMI are available to download free of charge at:

http://www.analystsreview.com/Aug-12-2014/PM/report.pdf

Harman International Industries Inc. Research Reports 

On August 7, 2014, Harman International Industries Inc. (Harman) reported Q4 FY 2014 (period ended June 30, 2014) net sales of $1.44 billion, up 22.2% YoY, helped by increased sales across all three divisions: Infotainment, Lifestyle, and Professional. The Company's Q4 FY 2014 net income attributable to Harman came in at $43.2 million or $0.62 per diluted share, compared to net income of $5.5 billion or $0.08 per diluted share in Q4 FY 2013. According to 9 analysts polled by Thomson Reuters, the Company was expected to post Q4 FY 2014 EPS of $1.21 (excluding special items) on revenues of $1.39 billion. The Company's full-year FY 2014 (period ended June 30, 2014) net sales improved 24.4% YoY to $5.3 billion, while net income attributable to Harman improved 64.8% YoY to $234.7 million. For FY 2015, the Company expects sales of c.$6 billion and EPS of c.$5.25, while for FY 2016, Harman expects sales of c.$6.85 billion. The full research reports on Harman are available to download free of charge at:

http://www.analystsreview.com/Aug-12-2014/HM/report.pdf

Mondelez International Inc. Research Reports 

On July 31, 2014, Mondelez International Inc. (Mondelez) announced the appointment of Mark Clouse as the Chief Growth Officer, a newly created position in the Company. Mondelez informed that in his new role, Mark Clouse will be responsible for all of the key areas of the Company's growth strategy, and will oversee the teams responsible for corporate strategy, global categories, global marketing, global sales, and research, development and quality. In addition, the Company is also planning to transition to a region category-led operating model worldwide starting January 1, 2015. The Company plans to implement this model in Latin America, Asia Pacific and EEMEA (Eastern Europe, Middle East and Africa) to drive growth, streamline decision-making and accelerate speed to market. The full research reports on Mondelez are available to download free of charge at:

http://www.analystsreview.com/Aug-12-2014/MDLZ/report.pdf

Nike Inc. Research Reports 

On August 7, 2014, Nike Inc. (Nike) reported that its Nike Hyperdunk 2014 City Pack will make its on-court debut during the upcoming 2014 World Basketball Festival (WBF) in Chicago between August 13, 2014 and August 17, 2014. Nike informed that each pair of shoes in the pack represents the pride, passion and culture of the game in Chicago, Los Angeles, New York and Washington, D.C. Further, its new pack of shoes has several performance benefits which include: lunarlon cushioning midsole that provide a soft, responsive ride; hyperfuse construction that creates a breathable, flexible upper; and flywire technology that delivers dynamic lockdown through the mid-foot. The Hyperdunk 2014 City Pack is available at select retailers and Nike.com effective from August 7, 2014. The full research reports on Nike are available to download free of charge at:

http://www.analystsreview.com/Aug-12-2014/NKE/report.pdf

WhiteWave Foods Co. Research Reports 

On August 7, 2014, WhiteWave Foods Co. (WhiteWave) reported 39.5% YoY growth in its Q2 2014 net sales to $837.9 million, reflecting the inclusion of Earthbound Farm and strong organic growth in both the North America and Europe segments. The Company's Q2 2014 net income came in at $34.4 million or $0.19 per diluted share, compared to net income of $31.2 million or $0.18 per diluted share in Q2 2013. According to 12 analysts polled by Thomson Reuters, the Company was expected to report Q2 2014 EPS of $0.22 (excluding special items) on revenues of $815.44 million. WhiteWave's H1 2014 total net sales improved 36.3% YoY to $1.7 billion, while net income stood at $66.8 million, compared to net income of $55.2 million in H1 2013. For Q3 2014, the Company expects net sales growth of approx. 30% and adjusted diluted EPS in the range of $0.25 and $0.26, while for full-year 2014, net sales growth rate is expected in low-thirties percent range and adjusted diluted EPS between $0.98 and $1.00. The full research reports on WhiteWave are available to download free of charge at:

http://www.analystsreview.com/Aug-12-2014/WWAV/report.pdf

About Analysts Review

We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://www.AnalystsReview.com

SOURCE Analysts Review